TY - JOUR AU - Rahman, K. M. AU - Sakr, W. A. PY - 2012 DA - 2012// TI - The therapeutic value of natural agents to treat miRNA targeted breast cancer in African-American and Caucasian-American women JO - Curr Drug Targets VL - 13 UR - https://doi.org/10.2174/138945012804545461 DO - 10.2174/138945012804545461 ID - Rahman2012 ER - TY - JOUR AU - He, M. AU - Guo, Q. AU - Hu, G. PY - 2011 DA - 2011// TI - Reversed urban–rural differences in breast cancer mortality (China, 2002–2008) JO - Breast Cancer Res Treat VL - 126 UR - https://doi.org/10.1007/s10549-010-1276-2 DO - 10.1007/s10549-010-1276-2 ID - He2011 ER - TY - JOUR AU - Zhang, B. N. AU - Zhang, B. AU - Tang, Z. H. AU - Xie, X. M. AU - Yang, H. J. AU - He, J. J. PY - 2012 DA - 2012// TI - [10-year changes and development of surgical treatment for breast cancer in China] JO - Zhonghua Zhong Liu Za Zhi VL - 34 ID - Zhang2012 ER - TY - JOUR AU - Yu, Z. G. AU - Jia, C. X. AU - Liu, L. Y. PY - 2012 DA - 2012// TI - The prevalence and correlates of breast cancer among women in Eastern China JO - PLoS One VL - 7 UR - https://doi.org/10.1371/journal.pone.0037784 DO - 10.1371/journal.pone.0037784 ID - Yu2012 ER - TY - JOUR AU - Jemal, A. AU - Siegel, R. AU - Xu, J. PY - 2010 DA - 2010// TI - Cancer statistics, 2010 JO - CA Cancer J Clin VL - 60 UR - https://doi.org/10.3322/caac.20073 DO - 10.3322/caac.20073 ID - Jemal2010 ER - TY - JOUR AU - Greco, F. AU - Vicent, M. J. PY - 2009 DA - 2009// TI - Combination therapy: opportunities and challenges for polymer-drug conjugates as anticancer nanomedicines JO - Adv Drug Deliv Rev VL - 61 UR - https://doi.org/10.1016/j.addr.2009.05.006 DO - 10.1016/j.addr.2009.05.006 ID - Greco2009 ER - TY - JOUR AU - Noordhuis, P. AU - Holwerda, U. AU - Wilt, C. L. PY - 2004 DA - 2004// TI - 5-Fluorouracil incorporation into RNA and DNA in relation to thymidylate synthase inhibition of human colorectal cancers JO - Ann Oncol VL - 15 UR - https://doi.org/10.1093/annonc/mdh264 DO - 10.1093/annonc/mdh264 ID - Noordhuis2004 ER - TY - JOUR AU - Sims, J. T. AU - Ganguly, S. S. AU - Bennett, H. PY - 2013 DA - 2013// TI - Imatinib reverses doxorubicin resistance by affecting activation of STAT3-dependent NF-kappaB and HSP27/p38/AKT pathways and by inhibiting ABCB1 JO - PLoS One VL - 8 UR - https://doi.org/10.1371/journal.pone.0055509 DO - 10.1371/journal.pone.0055509 ID - Sims2013 ER - TY - JOUR AU - Dirks-Naylor, A. J. AU - Tran, N. T. AU - Yang, S. PY - 2013 DA - 2013// TI - The effects of acute doxorubicin treatment on proteome lysine acetylation status and apical caspases in skeletal muscle of fasted animals JO - J Cachex Sarcopenia Muscle VL - 4 UR - https://doi.org/10.1007/s13539-013-0104-z DO - 10.1007/s13539-013-0104-z ID - Dirks-Naylor2013 ER - TY - JOUR AU - Eker, B. AU - Meissner, R. AU - Bertsch, A. PY - 2013 DA - 2013// TI - Label-free recognition of drug resistance via impedimetric screening of breast cancer cells JO - PLoS One VL - 8 UR - https://doi.org/10.1371/journal.pone.0057423 DO - 10.1371/journal.pone.0057423 ID - Eker2013 ER - TY - JOUR AU - Huang, X. AU - Chen, Y. J. AU - Peng, D. Y. PY - 2013 DA - 2013// TI - Solid lipid nanoparticles as delivery systems for Gambogenic acid JO - Colloids Surf B Biointerfaces VL - 102 UR - https://doi.org/10.1016/j.colsurfb.2012.08.058 DO - 10.1016/j.colsurfb.2012.08.058 ID - Huang2013 ER - TY - JOUR AU - Li, Q. AU - Cheng, H. AU - Zhu, G. PY - 2010 DA - 2010// TI - Gambogenic acid inhibits proliferation of A549 cells through apoptosis-inducing and cell cycle arresting JO - Biol Pharm Bull VL - 33 UR - https://doi.org/10.1248/bpb.33.415 DO - 10.1248/bpb.33.415 ID - Li2010 ER - TY - JOUR AU - Cheng, H. AU - Su, J. J. AU - Peng, J. Y. PY - 2011 DA - 2011// TI - Gambogenic acid inhibits proliferation of A549 cells through apoptosis inducing through up-regulation of the p38 MAPK cascade JO - J Asian Nat Prod Res VL - 13 UR - https://doi.org/10.1080/10286020.2011.605062 DO - 10.1080/10286020.2011.605062 ID - Cheng2011 ER - TY - JOUR AU - Yang, L. AU - Wang, M. AU - Cheng, H. PY - 2011 DA - 2011// TI - Gambogenic acid inhibits proliferation of A549 cells through apoptosis-inducing JO - Zhongguo Zhong Yao Za Zhi VL - 36 ID - Yang2011 ER - TY - JOUR AU - Yan, F. AU - Wang, M. AU - Chen, H. PY - 2011 DA - 2011// TI - Gambogenic acid mediated apoptosis through the mitochondrial oxidative stress and inactivation of Akt signaling pathway in human nasopharyngeal carcinoma CNE-1 cells JO - Eur J Pharmacol VL - 652 UR - https://doi.org/10.1016/j.ejphar.2010.11.018 DO - 10.1016/j.ejphar.2010.11.018 ID - Yan2011 ER - TY - JOUR AU - Chen, H. B. AU - Zhou, L. Z. AU - Mei, L. PY - 2012 DA - 2012// TI - Gambogenic acid-induced time- and dose-dependent growth inhibition and apoptosis involving Akt pathway inactivation in U251 glioblastoma cells JO - J Nat Med VL - 66 UR - https://doi.org/10.1007/s11418-011-0553-7 DO - 10.1007/s11418-011-0553-7 ID - Chen2012 ER - TY - JOUR AU - Martelli, A. M. AU - Tazzari, P. L. AU - Tabellini, G. PY - 2003 DA - 2003// TI - A new selective AKT pharmacological inhibitor reduces resistance to chemotherapeutic drugs, TRAIL, all-trans-retinoic acid, and ionizing radiation of human leukemia cells JO - Leukemia VL - 17 UR - https://doi.org/10.1038/sj.leu.2403044 DO - 10.1038/sj.leu.2403044 ID - Martelli2003 ER - TY - JOUR AU - Brognard, J. AU - Clark, A. S. AU - Ni, Y. PY - 2001 DA - 2001// TI - Akt/protein kinase B is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation JO - Cancer Res VL - 61 ID - Brognard2001 ER - TY - JOUR AU - Sokolosky, M. AU - Chappell, W. H. AU - Stadelman, K. PY - 2014 DA - 2014// TI - Inhibition of GSK-3beta activity can result in drug and hormonal resistance and alter sensitivity to targeted therapy in MCF-7 breast cancer cells JO - Cell Cycle VL - 13 UR - https://doi.org/10.4161/cc.27728 DO - 10.4161/cc.27728 ID - Sokolosky2014 ER - TY - JOUR AU - Wang, K. AU - Tang, Y. AU - Sun, M. PY - 2011 DA - 2011// TI - The mechanism of neogambogic acid-induced apoptosis in human MCF-7 cells JO - Acta Biochim Biophys Sin VL - 43 UR - https://doi.org/10.1093/abbs/gmr063 DO - 10.1093/abbs/gmr063 ID - Wang2011 ER - TY - JOUR AU - Zhou, J. AU - Luo, Y. H. AU - Wang, J. R. PY - 2013 DA - 2013// TI - Gambogenic acid induction of apoptosis in a breast cancer cell line JO - Asian Pac J Cancer Prev VL - 14 UR - https://doi.org/10.7314/APJCP.2013.14.12.7601 DO - 10.7314/APJCP.2013.14.12.7601 ID - Zhou2013 ER - TY - JOUR AU - Chien, A. J. AU - Moasser, M. M. PY - 2008 DA - 2008// TI - Cellular mechanisms of resistance to anthracyclines and taxanes in cancer: intrinsic and acquired JO - Semin Oncol VL - 35 UR - https://doi.org/10.1053/j.seminoncol.2008.02.010 DO - 10.1053/j.seminoncol.2008.02.010 ID - Chien2008 ER - TY - JOUR AU - Brown, I. AU - Shalli, K. AU - McDonald, S. L. PY - 2004 DA - 2004// TI - Reduced expression of p27 is a novel mechanism of docetaxel resistance in breast cancer cells JO - Breast Cancer Res VL - 6 UR - https://doi.org/10.1186/bcr918 DO - 10.1186/bcr918 ID - Brown2004 ER - TY - JOUR AU - Zhu, X. AU - He, Z. AU - Wu, J. PY - 2012 DA - 2012// TI - A marine anthraquinone SZ-685C overrides adriamycin-resistance in breast cancer cells through suppressing Akt signaling JO - Mar Drugs VL - 10 UR - https://doi.org/10.3390/md10040694 DO - 10.3390/md10040694 ID - Zhu2012 ER - TY - JOUR AU - Nicholson, K. M. AU - Anderson, N. G. PY - 2002 DA - 2002// TI - The protein kinase B/Akt signalling pathway in human malignancy JO - Cell Signal VL - 14 UR - https://doi.org/10.1016/S0898-6568(01)00271-6 DO - 10.1016/S0898-6568(01)00271-6 ID - Nicholson2002 ER - TY - JOUR AU - Wu, H. AU - Shekar, S. C. AU - Flinn, R. J. PY - 2009 DA - 2009// TI - Regulation of Class IA PI 3-kinases: C2 domain-iSH2 domain contacts inhibit p85/p110alpha and are disrupted in oncogenic p85 mutants JO - Proc Natl Acad Sci U S A VL - 106 UR - https://doi.org/10.1073/pnas.0902369106 DO - 10.1073/pnas.0902369106 ID - Wu2009 ER - TY - JOUR AU - Dey, N. AU - Crosswell, H. E. AU - De, P. PY - 2008 DA - 2008// TI - The protein phosphatase activity of PTEN regulates SRC family kinases and controls glioma migration JO - Cancer Res VL - 68 UR - https://doi.org/10.1158/0008-5472.CAN-07-1182 DO - 10.1158/0008-5472.CAN-07-1182 ID - Dey2008 ER - TY - JOUR AU - Cheng, G. Z. AU - Park, S. AU - Shu, S. PY - 2008 DA - 2008// TI - Advances of AKT pathway in human oncogenesis and as a target for anti-cancer drug discovery JO - Curr Cancer Drug Targets VL - 8 UR - https://doi.org/10.2174/156800908783497104 DO - 10.2174/156800908783497104 ID - Cheng2008 ER - TY - JOUR AU - Manning, B. D. AU - Cantley, L. C. PY - 2007 DA - 2007// TI - AKT/PKB signaling: navigating downstream JO - Cell VL - 129 UR - https://doi.org/10.1016/j.cell.2007.06.009 DO - 10.1016/j.cell.2007.06.009 ID - Manning2007 ER - TY - JOUR AU - Yu, X. J. AU - Han, Q. B. AU - Wen, Z. S. PY - 2012 DA - 2012// TI - Gambogenic acid induces G1 arrest via GSK3beta-dependent cyclin D1 degradation and triggers autophagy in lung cancer cells JO - Cancer Lett VL - 322 UR - https://doi.org/10.1016/j.canlet.2012.03.004 DO - 10.1016/j.canlet.2012.03.004 ID - Yu2012 ER - TY - JOUR AU - Yan, F. AU - Wang, M. AU - Li, J. PY - 2012 DA - 2012// TI - Gambogenic acid induced mitochondrial-dependent apoptosis and referred to phospho-Erk1/2 and phospho-p38 MAPK in human hepatoma HepG2 cells JO - Environ Toxicol Pharmacol VL - 33 UR - https://doi.org/10.1016/j.etap.2011.12.006 DO - 10.1016/j.etap.2011.12.006 ID - Yan2012 ER - TY - JOUR AU - Clark, A. S. AU - West, K. AU - Streicher, S. PY - 2002 DA - 2002// TI - Constitutive and inducible Akt activity promotes resistance to chemotherapy, trastuzumab, or tamoxifen in breast cancer cells JO - Mol Cancer Ther VL - 1 ID - Clark2002 ER -